For buyers
Plant-touching vs ancillary investment
Federal and state law current as of September 2026 — verify with counsel.
Key takeaways
- As of September 2026, medical marijuana is Schedule III; adult-use remains Schedule I (Federal Register 2026-08176 and pending hearing).
- 280E still hits adult-use SG&A; medical books may take ordinary deductions — apportion dual licenses.
- SBA loans are unavailable for plant-touching targets (SOP 50 10 8).
- Deals close on regulatory approval; control does not move early.
- Single-store commentary multiples of about 3x–6x EBITDA are trade ranges, not appraisals (2025–2026 commentary).
Plant-touching vs ancillary investment is a side-by-side underwriting choice. The wrong column is how buyers overpay and sellers wait a year. This page is written for buyers and for ancillary licenses specifically. It is not legal or tax advice. Federal and state law current as of September 2026 — verify with counsel.
Treat Plant-touching vs ancillary investment as a state-license file with a federal tax and banking overlay. Schedule III medical relief is real for qualifying activity and irrelevant to an adult-use-only book. Hemp SKUs face CRS IN12620 on the 2026 hemp definition on 12 November 2026. Do not import a 2021 multiple onto that fact pattern.
| Topic | Working rule (verify, September 2026) |
|---|---|
| Audience | buyers |
| License lens | ancillary licenses specifically |
| Contrast markets | Massachusetts / Washington / Florida |
| SBA | Unavailable for plant-touching (SOP 50 10 8) |
| Hemp clock | P.L. 119-37 redefinition 12 November 2026 |
| Commentary multiple (not an appraisal) | 4x–43x normalized earnings |
Holdbacks that belong on Plant-touching vs ancillary investment — why does this change Plant-touching vs ancillary investment?
Tax, inventory, and compliance residuals sit in escrow or a holdback. Plant-touching vs ancillary investment that closes “clean” with open city tax is a gift to the buyer’s counsel.
What a commentary multiple is not on Plant-touching vs ancillary investment — what belongs on Plant-touching vs ancillary investment?
Trade notes still cite about 5x–53x normalized earnings for a clean single store. Public MSO chatter near 4.16x EV/EBITDA for 2025 is not a value for Plant-touching vs ancillary investment.
Hemp overlay if Plant-touching vs ancillary investment touches SKUs — why does this change Plant-touching vs ancillary investment?
P.L. 119-37 and CRS IN12620 on the 2026 hemp definition reset the definition on 12 November 2026. If Plant-touching vs ancillary investment includes delta-8 or other intoxicating hemp, underwrite the post-rule catalog.
MSA risk around Plant-touching vs ancillary investment — how should you read this on Plant-touching vs ancillary investment?
A management agreement that moves control before approval is a license event. Plant-touching vs ancillary investment does not get a clever close by calling the buyer a consultant.
Diligence order for Plant-touching vs ancillary investment — what belongs on Plant-touching vs ancillary investment?
Eligibility, then local host status, then track-and-trace, then tax, then lease. The checklist stays in the working set.
Documents that actually move Plant-touching vs ancillary investment — why does this change Plant-touching vs ancillary investment?
License, local authorization, lease consent, tax clearance, 5 months of seed-to-sale exports, violation history, and the ownership chart. Missing one of those is not a formatting issue.
Who should not attempt Plant-touching vs ancillary investment — what should you verify for Plant-touching vs ancillary investment?
A buyer who cannot pass background or residency. An owner inside a holding period. A non-citizen who has not spoken to immigration counsel. USCIS still treats marijuana conduct as a controlled-substance issue.
How HedgeStone treats Plant-touching vs ancillary investment — why does this change Plant-touching vs ancillary investment?
Jason Taken will say if Plant-touching vs ancillary investment is transferable before anyone writes a CIM. He is a business broker, not an attorney and not a licensed operator. No invented listings, no invented MSO names.
Successor liability sitting under Plant-touching vs ancillary investment — how should you read this on Plant-touching vs ancillary investment?
Cannabis tax debt does not vanish because someone chose an asset sale. Clearance certificates and holdbacks exist for Plant-touching vs ancillary investment. See tax holdbacks.
Banking after Plant-touching vs ancillary investment — how should you read this on Plant-touching vs ancillary investment?
FinCEN FIN-2014-G001 is still the SAR frame. A new owner who assumes the seller’s bank will keep the account is guessing. Model cash handling until the successor account is real.
When to walk away from Plant-touching vs ancillary investment — what breaks Plant-touching vs ancillary investment?
If the license is locked, the city will not host the buyer, the books cannot be rebuilt, or the hemp catalog dies in November 2026, the honest answer is stop. Plant-touching vs ancillary investment is not improved by optimism.
Partner and dispute uses of Plant-touching vs ancillary investment — how should you read this on Plant-touching vs ancillary investment?
Buyouts and shareholder fights still need a method, not a slogan. Label ranges. Do not pretend a liquor-store rule prices Plant-touching vs ancillary investment.
Inventory and biomass on Plant-touching vs ancillary investment — what breaks Plant-touching vs ancillary investment?
What is on the floor at close has to match the state system. Failed tests and unsold canopy are price, not atmosphere. Count it.
Real estate attached to Plant-touching vs ancillary investment — what belongs on Plant-touching vs ancillary investment?
The building can be the deal or the trap. No cannabis-use clause means Plant-touching vs ancillary investment cannot operate after assignment. Sale-leasebacks are capital, not magic.
Cited sources that govern Plant-touching vs ancillary investment: FinCEN FIN-2014-G001 remains the SAR frame banks actually use. SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical. SAFE Banking Act of 2026, S.4942 and H.R.9471 were introduced in 2026 and are not law. Hemp SKUs must be read against CRS IN12620 on the 2026 hemp definition and CRS IF13136; the redefinition date is 12 November 2026.
What to bring to the intro call — how should you read this on Plant-touching vs ancillary investment?
Book twenty minutes with Jason Taken at HedgeStone Business Advisors. For Plant-touching vs ancillary investment, bring the license class, the state, the local authorization status, and whether a buyer or target is already in the room. There is no form on this site and no invented listing book. He is a business broker, not an attorney and not a licensed cannabis operator.
Related pages for Plant-touching vs ancillary investment — what belongs on Plant-touching vs ancillary investment?
Read retail vs cultivation next if that file is open on Plant-touching vs ancillary investment. MSO vs private is the companion page when Plant-touching vs ancillary investment needs that angle. Keep plant-touching vs ancillary in the working set for Plant-touching vs ancillary investment. Read buy vs apply next if that file is open on Plant-touching vs ancillary investment. consideration types is the companion page when Plant-touching vs ancillary investment needs that angle. Keep sell in the working set for Plant-touching vs ancillary investment. Read buy next if that file is open on Plant-touching vs ancillary investment. valuation is the companion page when Plant-touching vs ancillary investment needs that angle.
Summary on Plant-touching vs ancillary investment — what belongs on Plant-touching vs ancillary investment?
Plant-touching vs ancillary investment turns on approval, after-tax cash, and the license class. Federal law current as of September 2026 is a schedule split, not a green light. Verify every rate, cap, and clock with counsel.
Which public sources belong on this file?
Pull DEA drug scheduling, DEA diversion schedules, FDA cannabis / CBD page, IRS marijuana industry page before you price the file. A forum post is not a substitute.
How should you underwrite Plant-touching vs ancillary investment?
Plant-touching vs ancillary investment has to map as a license-and-tax file. In Arizona, scarcity can dominate. In Oregon, paper value can be near zero. Cited sources that govern Plant-touching vs ancillary investment: Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order. IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E. FinCEN FIN-2014-G001 remains the SAR frame banks actually use. SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical.
| Check | Arizona | Oregon |
|---|---|---|
| Transfer / host | Verify agency | Verify city |
| Tax / 280E mix | Medical slice | Adult-use slice |
What does a 280E-literate CPA ask?
Plant-touching vs ancillary investment has to rebuild as a license-and-tax file. In Massachusetts, scarcity can dominate. In Washington, paper value can be near zero. Cited sources that govern Plant-touching vs ancillary investment: Hemp SKUs must be read against CRS IN12620 on the 2026 hemp definition and CRS IF13136; the redefinition date is 12 November 2026. Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order. IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E. FinCEN FIN-2014-G001 remains the SAR frame banks actually use.
| Check | Massachusetts | Washington |
|---|---|---|
| Transfer / host | Verify agency | Verify city |
| Tax / 280E mix | Medical slice | Adult-use slice |
Frequently asked questions
How long can a license transfer take?
Published clocks vary by state and completeness. Treat 60–180+ days after a complete packet as a broker range unless the agency publishes a deadline. Arizona and Oregon do not share a clock on Plant-touching vs ancillary investment.
Can control move before approval?
Not if you want to keep the license. Stage closing and keep any MSA inside what the statute allows. Plant-touching vs ancillary investment is still an agency event.
Will SBA finance a plant-touching purchase?
No. [SBA SOP 50 10 8](https://www.sba.gov/document/sop-50-10-lender-development-company-loan-programs) treats plant-touching marijuana businesses as ineligible for 7(a) and 504, including medical. Plant-touching vs ancillary investment needs another stack.
What does HedgeStone actually do here?
Eligibility pre-screen, confidential match, METRC-aware pricing, and an approval-contingent process. Not a guaranteed price or a guaranteed yes. That is the job on Plant-touching vs ancillary investment.
Is this legal or tax advice?
No. Educational only. Use cannabis-specialized counsel and a 280E-literate CPA. Jason Taken is a business broker, not an attorney and not a licensed operator.
Which records actually prove the story?
Track-and-trace, tax filings, the lease cannabis-use clause, and a cap table that matches the application. A vanity P&L is a brochure when you are underwriting Plant-touching vs ancillary investment.
Sources
- Federal Register 2026-08176 (28 April 2026) — medical / FDA-approved marijuana to Schedule III — https://www.federalregister.gov/d/2026-08176
- FinCEN FIN-2014-G001 — BSA expectations for marijuana-related businesses — https://www.fincen.gov/resources/statutes-regulations/guidance/bsa-expectations-regarding-marijuana-related-businesses
- SBA SOP 50 10 8 (effective 1 June 2025) — marijuana ineligibility — https://www.sba.gov/document/sop-50-10-lender-development-company-loan-programs
- Congress.gov S.4942 — SAFE Banking Act of 2026 (introduced, not enacted) — https://www.congress.gov/bill/119th-congress/senate-bill/4942
- Congress.gov H.R.9471 — companion SAFE Banking bill — https://www.congress.gov/bill/119th-congress/house-bill/9471
- DEA drug scheduling — https://www.dea.gov/drug-information/drug-scheduling
- DEA diversion schedules — https://www.deadiversion.usdoj.gov/schedules/
- FDA cannabis and CBD page — https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd
- CRS IF13136 / IN12620 — hemp definition change effective 12 November 2026 (P.L. 119-37) — https://www.congress.gov/crs-product/IN12620
- IRC §280E — https://www.law.cornell.edu/uscode/text/26/280E
- Viridian Capital public commentary — Tier 1 U.S. MSO EV/EBITDA ~4.16x (2025 consensus)